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ABSTRACT  
Objective: The objective of the present investigation was to design and evaluate a gel containing lycopene loaded colloidal microparticles.  
Methods: The lycopene loaded colloidal microparticles were successfully prepared by Cloud point technique to form colloids using Tween 40 and 
Tween 60 surfactant solution and then incorporated into microparticles by solvent evaporation method using polymer like HPMC and ethyl 
cellulose. These colloidal microparticles were evaluated for particle size (PS), drug loading (DL), entrapment efficiency (EE), Scanning Electron 
Microscopy (SEM). Further, these colloidal microparticles were incorporated into a topical formulation i.e., gel. This topical formulation was then 
evaluated for macroscopic examination, viscosity, drug content, spreadability, antioxidant activity, in vitro permeation and release kinetics. 
Results: Colloidal microparticles were successfully prepared and the particle size, drug loading and entrapment efficiency were found to be 
249.45±14.2 μm, 49.8±0.96 % and 93.4±0.26 % respectively. FTIR study depicted no chemical interaction between pure drug lycopene and other 
excipients. The topical formulation showed sustained release and followed Korsmeyer-Peppas release kinetics model. 
Conclusion: The sustained release topical formulation of lycopene was successfully prepared using Tween 40 and Tween 60 surfactant solution and 
combination of HPMC and ethyl cellulose and evaluated for several parameters.  
Keywords: Lycopene, Sustained release, HPMC, Tween 40 and 60, Colloidal Microparticles 




Lycopene is a powerful antioxidant which can prevent human skin 
against UVR-induced effects [1]. Lycopene helps in providing 
protection against acute and potentially longer-term aspects of 
photo damage [2]. Lycopene in its original form is a lyophilic drug 
[3]. Lycopene-based product had a much greater protective ability 
from photodamage than the product containing the mixture of 
vitamins and lycopene has suitable characteristics to be used 
successfully in the prevention of cutaneous damage by free radicals 
[4]. The antioxidant ability of lycopene was probably due to its high 
reductive power. It act as a preventative agent via inhibition of 
epidermal ornithine decarboxylase activity, reducing inflammatory 
responses, maintaining normal cell proliferation and possibly 
preventing DNA damage as indicated by blocking the necessitating 
step of apoptosis following UVB injury [5]. It has poor aqueous 
solubility and this reduces the flexibility of drug formulation and 
administration [6]. 
Microparticle entrapped micelles is a delivery system in which the 
particles of the micellar range are ensemble for drug and gene delivery 
in specific parts of the body. Microparticles containing micelles have 
the potential for delivering micelle encapsulated hydrophobic drug on 
targeted site [7-11]. Micelles have been used as drug carriers for 
administration and exhibit many advantages including their ease of 
production, long circulation times and having surfaces that are readily 
modified with targeting ligands. Drug loaded colloidal microparticles 
can sustain the release of drug and provide patient compliance by ease 
of application through topical drug delivery system. The lower 
solubility of lycopene in aqueous solvents makes it a selective 
candidate for the improvement of solubility and delivering the drug by 
formulating colloidal microparticles [12]. 
In the present investigation, sustained release topical formulation of 
lycopene loaded colloidal microparticles was prepared. Colloids 
were prepared by Cloud point technique using Tween 40 and Tween 
60 surfactant solution and then incorporated into microparticles by 
solvent evaporation method using polymer like HPMC and ethyl 
cellulose. The formulated colloidal microparticles were also 
evaluated for different parameters such as Percentage yield, Particle 
Size, Entrapment efficiency, FTIR study and SEM. The optimised 
colloidal microparticles were incorporated into gel and evaluated for 
macroscopic examination, viscosity, drug content, spreadability, 
antioxidant activity, in vitro permeation and release kinetics. 
MATERIALS AND METHODS  
Materials  
Lycopene was obtained as a gift sample from Ion Healthcare (P) Ltd, 
Baddi. Other materials mainly Methanol, Chloroform, hexane, 
Petroleum ether, Tween 40 and Tween 60 used were of analytical 
grades and procured commercially. 
Formulation of drug loaded colloids 
Drug loaded colloids were formulated by Cloud Point Technique. The 
cloud point temperature (CPT) were obtained by placing the test 
tubes each containing a surfactant solution of 1% (1 ml in 100 ml), 
5%, 10%, 15% and 25% (v/v) of Tween 60, Tween 40 and mixture 
of Tween 40 and Tween 60 into a temperature-controlled bath. The 
sample solutions were heated to a temperature where cloudy 
appearance was visualized. The temperature at the first sign of the 
turbidness was taken as the CPT [13].  
Micellar solubilization 
Micellar solubilization of lycopene was performed by employing 
cloud point technique, wherein drug was solubilized in surfactant 
solution at CPT. Aqueous surfactant solutions of 1%, 5%, 15% and 
25% (v/v) of Tween 60, Tween 40 and mixture of Tween 40 and 
Tween 60 were used as solubilizing media. The surfactant solutions 
(5 ml) were taken in centrifuge tubes, heated in a water bath up to 
CPT and excess amount of lycopene was added under stirring, 
solutions were cooled to room temperature (RT) and the solubility 
of lycopene was estimated. These lots were kept under shaking at RT 
using orbital shaker for 24h to attain equilibrium. The aliquots of 
these samples were centrifuged, filtered through a 0.45 mm nylon 
membrane filter, suitably diluted with n-hexane and were subjected 
to UV spectrophotometric analysis of lycopene at 517 nm.  
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Formulation of colloidal microparticles  
Microparticles formulations using combination of hydroxypropyl 
methyl cellulose (HPMC) and ethyl cellulose as a carrier polymer 
were prepared using solvent evaporation technique. Desired 
quantity of HPMC and ethyl cellulose polymer was dissolved in 8.5 
ml of acetone and dispersed by using a magnetic stirrer. The micellar 
solution of lycopene was added to the polymer solution and mixed 
for 15 min, followed by magnesium stearate (100 mg) and then 
mixed thoroughly. The resulting dispersion was added in a thin 
stream to a mixture of 90 ml light liquid paraffin contained in a 250 
ml beaker, while stirring at 700 rpm using a mechanical stirrer.  
Stirring was continued for 3 h until the acetone evaporated 
completely. The microparticles formed were filtered using filter 
paper. The residue was washed 4-5 times with 50 ml portions of n-
hexane. The product was then dried at room temperature for 24 h 
[14-17]. The composition is given in table 1. 
 
Table 1: Composition of various formulations of colloidal microparticles 
Ingredients (mg/ml) Formulations 
M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ethyl cellulose 10 15 20 10 15 20 10 15 20 
HPMC 5 10 20 5 10 20 5 10 20 
Micellar solution (ml) 5.1 5.1 5.1 3.6 3.6 3.6 4.1 4.1 4.1 
 
Drug-loading efficiency and encapsulation efficiency  
The amount of lycopene encapsulated in the microparticles was 
measured by an ultraviolet detector at the λmax value of 507 nm. 
The colloidal microparticles were suitably diluted with n-hexane and 
filtered before determination. Encapsulation efficiency (EE %) and 
drug loading (DL %) was calculated with the following equations 
[18, 19]:  
EE% =
Actual amount of drug encapsulated in microparticles
initial amount of drug used in microparticles
∗ 100 
DL% =
Weight of drug in microparticles
Weight of particles
∗ 100  
Actual amount of drug encapsulated in microparticles is calculated 
by: A= ɛcl 
Particle size analysis 
A thin film of microparticles was spread on a slide and covered with 
cover slip. The slide was observed under optical microscope [17]. 
Yield of colloidal microparticles 
The Yield of colloidal microparticles was calculated by given 
formulae [20, 21].  
% yield =  
Actual weight of product
Total weight of excipients and drugs
∗ 100 
Fourier-transform infrared spectroscopy  
FTIR spectrum of pure lycopene and lycopene and tween 60 were 
observed on FTIR spectrophotometer. FTIR spectroscopy was 
carried out for investigating any kind of chemical interactions 
among pure lycopene and other excipients in formulation [22, 23].  
Scanning electron microscope (SEM) 
The morphology of prepared Colloidal microparticles was observed 
using a Scanning Electron Microscope (SEM) [24]. 
Formulation of colloidal microparticles incorporated gel 
The weighed amount of Carbopol 934 LR powder was slowly 
dispersed in 50% distilled water with vigorous stirring, so as to 
avoid the clump formation and air entrapment. After complete 
dispersion, the gel solution was kept in dark for 24 h for complete 
swelling of Carbopol. Accurately weighed amount of Lycopene 
colloidal microparticles were then incorporated in Carbopol gel with 
continuous stirring. In another beaker other ingredients were 
dissolved in remaining 25% distilled water with moderate heating 
and stirring. The above solution was added slowly into the Carbopol 
gel containing lycopene with continuous stirring using magnetic 
stirrer. Care has been taken during preparation to avoid entrapment 
of air bubbles in a gel. Finally formed gel was then neutralized by 
sufficient quantity of sodium hydroxide solution (1% w/v). Final 
volume of formulation was adjusted by remaining amount of 
distilled water [25-28]. 
 
Table 2: Composition of various formulations of colloidal microparticles loaded gel 
S. No. Ingredients Quantities (% w/w) 
G1 G2 G3 G4 G5 G6 
1 Colloidal Microparticles 1.5 1.5 1.5 1.5 1.5 1.5 
2 Carbopol 934 0.5 1 1.5 - - - 
3 HPMC - - - 3 3.5 4 
4 Glycerin 5 5 5 5 5 5 
5 Triethanolamine 2 2 2 2 2 2 
6 Methyl paraben 0.20 0.20 0.20 0.20 0.20 0.20 
7 Propyl paraben 0.05 0.05 0.05 0.05 0.05 0.05 
8 Sodium hydroxide q. s. q. s. q. s. q. s. q. s. q. s. 
9 Distilled water q. s. q. s. q. s. q. s. q. s. q. s. 
 
Macroscopic examination 
The physical appearance of the prepared formulation were checked 
and compared visually for their colour, homogeneity, consistency [29]. 
Determination of pH 
The pH values of gel formulations were determined by using digital 
pH meter [30, 31]. 
Determination of viscosity 
Brookfield digital viscometer was used to measure the viscosity (in 
cps) of the prepared gel formulation [32]. 
Determination of drug content 
1g formulation was taken in a 50 ml volumetric flask and made up to 
volume with hexane and shaken well to dissolve the active constituents 
in hexane. The solution was filtered through Whatman filter paper and 
0.1 ml of the filtrate was pipetted out and diluted to 10 ml with hexane. 
The content of active constituents was estimated spectrophotometrically 
by using standard curve plotted at 470.8 nm [33]. 
Determination of spreadability 
Spreading coefficient was determined by apparatus which consisted 
of a wooden block that was attached to a pulley at one end. 
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Spreading coefficient was measured on the basis of ‘Slip’ and ‘Drag’ 
characteristics of gels.  
Determination of antioxidant activity of formulated gel 
1 gm of sample was taken and 0.67% of aqueous thiobarbituric acid 
(2 ml) and benzene (2.5 ml) were added. This mixture was shaken 
continuously for 1h using mechanical shaker. After 1h supernatant 
was taken and placed in boiling water bath for 1h. After cooling, 
absorbance of supernatant was measured at 540 nm using UV visible 
spectrophotometer. The TBA value was expressed as mg. 
malondialdehyde/kg sample using the following equation:  
TBA = 7.8 × O. D. 
Where, O. D. is the absorbance at 540 nm. 
In vitro permeation test 
The in vitro permeation tests were performed using Franz diffusion 
cell. The diffusional area of the cell is 1.75 cm2
RESULTS AND DISCUSSION 
 and the receptor 
compartment had a capacity of approximately 10.5 ml. The membrane 
was cut to a diameter of 25 mm and saturated for 30 min in receptor 
medium (phosphate buffer pH 7.4) before starting the experiment. The 
cell was filled with degassed receptor medium and the membrane was 
placed in the top of the receptor compartment and checked for air 
bubbles. An aliquot of the sample was measured with the aid of a 
syringe and then placed in the cavity of a dosage wafer (donor 
compartment), on top of the membrane. The amount applied was 
around 50 mg of gel. With a spatula, the gel was spread uniformly 
filling the donor compartment. A glass disk was carefully placed on the 
sample to occlude it, and an aligner cap was then used to centralize the 
assembly, which was held together by a clamp. The receptor medium 
was maintained at 37±2 °C under constant stirring. To characterize the 
drug release, 1 ml samples were collected after 1, 2, 3, 4, 5, 6 and 7 h. 
After sampling, the volume collected is replaced with fresh receptor 
medium. The amount of lycopene is assayed by UV analysis [34]. 
Micellar solubilization  
The surfactant solutions (5 ml) were taken in centrifuge tubes, 
heated in a water bath up to CPT and excess amount of lycopene was 
added under stirring, solutions were cooled to room temperature 
(RT) and the solubility of lycopene was estimated by UV 
Spectroscopy and results are tabulated in table 3. 
 
Table 3: Solubility of lycopene in various surfactant solutions 
S. No. Concentration (% v/v) Solubility of lycopene (mg/ml) 
Tween 40 Tween 60 Mixture of Tween 40 and 60 
1 1 3.404 5.7 5.217 
2 5 14.465 19.8 17.2 
3 10 38.76 53.9 47.4 
4 15 58.656 82.3 72.84 
 
Evaluation of colloidal microparticles 
The yield, particle size, drug loading and entrapment efficiency 
increases with increase in polymer concentration. From the results, 
it was observed that the drug is uniformly distributed within the 
polymer matrix. These findings were found to be consistent with 
other studies [25]. The particle size increases with the increase in 
the polymer concentration in the microparticles. This was due to 
increase in relative viscosity, which led to increase in particle size. A 
higher concentration of polymer produces more viscous dispersion, 
which formed larger droplets and consequently larger 
microparticles [26, 27]. These results are depicted in table 4. 
 
Table 4: Evaluation of colloidal microparticles 
Formulation code % yield Particle size (µm) Drug loading (%) Entrapment efficiency (%) 
M1 87.94 222.1 45.92±0.28 70.99±0.54 
M2 90.51 256.5 41.97±1.16 77.56±1.22 
M3 96.4 378.6 35.64±1.28 84.75±1.08 
M4 83.45 235.6 53.78±0.83 78.9±1.12 
M5 91.78 249.4 49.8±0.96 93.4±0.26 
M6 95.7 362.5 38.04±0.88 89.8±0.41 
M7 85.42 228.7 50.32±1.22 75.58±1.52 
M8 90.38 263.4 43.54±0.47 80.34±0.77 




Fig. 1: FTIR spectra of Lycopene drug 
































































































Bansal et al. 
Int J App Pharm, Vol 11, Issue 6, 2019, ??-?? 
168 
 
Fig. 2: FTIR spectra of lycopene and tween 60 
 
Fourier-transform infrared spectroscopy  
The FTIR spectra of lycopene exhibited principle peaks at wave 
numbers 632.43, 701.10, 761.14, 853.39, 989.48, 1075.80, 
1146.94, 1359.22, 1633.23, 2923.02 and 3311.05 cm-1
After considering the particle size and entrapment efficiency as 
optimization parameters the formulation M5 was considered as the 
best formulation having maximum entrapment efficiency and 
optimum particle size. 
 indicating 
the conformation of lycopene. In the FTIR spectra of physical 
mixture of drug with excipients, the principle peaks of drug were 
present at the above numbers. So, from the spectrum, it can be 
concluded that there was no interaction between drug and 
excipients used in the formulation. The FTIR spectrum of pure 
lycopene and lycopene and tween 60 are shown in fig. 1 and fig. 
2. 
Surface morphology 
Surface morphology of colloidal microparticles of formulation M5 
was investigated with the Scanning electron microscope. SEM 
photomicrograph is shown in fig. 3. The particle surface was found 
to be slightly wrinkled, irregularly shaped and discrete. The 
smoothness of the surface may increase with the increasing 
concentration of polymer. Very less particulate matter of the drug 
were seen on the surface of the microparticles indicating uniform 
distribution of the drug in the polymer network. The roughness of 
the microparticles can be due to washing out of the surfactant 
solution and also due to solvent evaporation [27, 28]. 
 
 
Fig. 3: Scanning electron photomicrographs of colloidal microparticles 
 
Evaluation of gel 
The gel containing colloidal microparticles formulations were 
clear and transparent with a smooth and homogeneous 
appearance with carbopol and white viscous with HPMC. The pH 
values of all prepared formulation of gel containing colloidal 
microparticles ranged from 5.8 to 6.8. The pH of the formulations 
was considered within acceptable pH range (5.5-6.5) and pH 
measurement was essential to ensure non-irritating nature of the 
formulation [39, 40]. The viscosity of gel increased with increase 
in polymer concentration. The spreadability decreased with 
increased polymer concentration. Lesser the time taken for 
separation of two slides, better the spreadability [41]. Drug 
content was calculated using the equation, which was obtained by 
linear regression analysis of calibration curve. The drug content 
was observed in the range of 91.62 to 95.48%. The macroscopic 
examination, pH, viscosity, spreadability and drug content are 
represented in table 5. 
  
Table 5: Evaluation of colloidal microparticles loaded gel 
Parameters Formulation code 
G1 G2 G3 G4 G5 G6 
Appearance Clear Clear Clear White viscous White viscous White viscous 
pH 5.8 6.1 6.8 5.5 6.0 6.4 
Viscosity (cps) 505 717 923 381 535 721 
Drug Content (%) 91.6±0.02 95.4±0.05 92.3±0.03 89.8±0.07 93.4±0.8 91.8±0.9 
Spreadability 13.6 10 8.82 15.7 12.8 10.2 
Antioxidant value  1.7 2.69 1.73 1.4 1.7 1.6 
(mean±SD, n=3) 
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In vitro permeation test 
The in vitro permeation tests were performed using Franz 
diffusion cell. The cumulative percentage drug release from gel 
loaded with colloidal microparticles showed that the cumulative 
drug release from gel was in descending order i.e., 
G1>G2>G4>G5>G3>G6. The amount of drug release or permeation 
through the cellophane membrane was showed to be based on 
viscosity or concentration of gelling agent. The drug release was 
found to decrease with increase in Carbopol concentration. In vitro 
release data of lycopene from gel loaded with colloidal 
microparticles is tabulated in table 6. 
 
Table 6: % cumulative drug release 
Time (h) % cumulative drug release 
G1 G2 G3 G4 G5 G6 
1 7.4±0.67 5.4±0.90 4.2±1.4 6.6±0.08 5±0.08 3.8±1.7 
2 12.4±0.35 11.8±0.46 9.7±0.6 11.1±0.5 9.86±1.2 8.9±1.1 
3 16.3±1.45 16.0±0.33 14.2±0.7 14.9±0.4 14.6±0.5 12.1±0.4 
4 23.9±0.89 20.2±0.74 17.4±0.2 22.1±0.7 18.3±0.8 15.5±0.07 
5 34.1±0.57 27.3±1.25 24.7±0.5 30.2±0.09 25.2±0.96 21.9±0.2 
6 43.6±0.45 39.7±0.82 31.0±1.2 36.5±0.1 32.05±0.4 27.2±0.08 
7 66.6±1.21 60.9±0.75 42.8±1.8 57.8±0.67 43.9±0.09 37.5±0.9 
mean±SD, n=3 
 
Table 7: In vitro drug release profile 
Model name Formulation code 
G1 G2 G3 G4 G5 G6 
r r2 r2 r2 r2 r2 2 
Zero order model 0.9588 0.948 0.981 0.958 0.982 0.981 
First order model 0.908 0.902 0.964 0.915 0.96 0.968 
Higuchi model 0.919 0.908 0.954 0.921 0.954 0.955 
Korsmeyer-Peppas model 0.973 0.979 0.993 0.977 0.993 0.993 
 
Determination of release kinetics 
The mathematical models were used to evaluate the kinetics and 
mechanism of drug release. The model that gave high correlation 
coefficient (r) value was considered as the best fit of the release data 
[42]. The in vitro drug release profiles of various models are 
tabulated in table 7. 
A graphical representation of the log cumulative percentage drug 
release vs. log time originated as a straight line shown in fig. 4. The 
release mechanism deviates from the Fickian diffusion following 
an anomalous diffusion or non-fickian diffusion, which referred to 




Fig. 4: Korsmeyer-peppas graph 
 
Table 7 revealed that the Korsmeyer-Peppas equation was followed 
for the in vitro diffusion of gel containing colloidal microparticles. 
The Korsmeyer-Peppas equation gave the value of n which is 5.6 i.e. 
higher than 0.45. The diffusion coefficient of Korsmeyer-Peppas 
equation showed that the Non-Fickian mechanism was basically 
involved in the drug release from gel containing colloidal 
microparticles. 
CONCLUSION 
In a nutshell to conclude, colloidal microparticles system is a vital tool in 
improving the solubility of lipophilic drug. The current studies resulted 
in the successful development of sustained release gel containing 
colloidal microparticles of lycopene. The lycopene’s lipophilic nature was 
masked by formulating micelles using Tween 40 and Tween 60. These 
colloids were then converted into solid product by forming 
microparticles. These colloidal microparticles were incorporated into 
topical formulation which showed sustained release and grossly 
improve the patient compliance. The formulation could be a successful 
approach to prevent human skin against UVR-induced effects. 
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